Activation of Toll-like Receptors by Microbial Lipoproteins

References

• Medzhitov R, Preston-Hurlburt P, Janeway CAJ. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394–7.
   PubMed Web of Science ®Google Scholar
• Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998; 95: 588–93.
   PubMed Web of Science ®Google Scholar
• Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998; 395: 284–8.
   PubMed Web of Science ®Google Scholar
• Kirschning CJ, Wesche H, Ayres TM, Rothe M. Human Toll-like receptor 2 confers responsiveness to bacterial lipo-polysachharide. J Exp Med 1998; 188: 2091–7.
   PubMed Web of Science ®Google Scholar
• Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, et al. MD-2, a molecule that confers lipopolysac-charide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189: 1777–82.
   PubMed Web of Science ®Google Scholar
• Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085–8.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11: 443–51.
   PubMed Web of Science ®Google Scholar
• Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000; 165: 618–22.
   Google Scholar
• Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A. The human toll signaling pathway: divergence of nuclear factor and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 1998; 187: 2097–101.
   Google Scholar
• Yang RB, Mark MR, Gurney AL, Godowski PJ. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J Immunol 1999; 163: 639–43.
   PubMed Web of Science ®Google Scholar
• Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11: 115–22.
   Google Scholar
• Maillard J, Bloom BR. Immunological adjuvants and the mechanism of cell cooperation. J Exp Med 1972; 136: 185–90.
   PubMedGoogle Scholar
• Zhang M, Gately MK, Wang E, Wolf SF, Lu SZ, Modlin RL, et al. Interleukin-12 at the site of disease in tuberculosis. J Clin Invest 1994; 93: 1733–9.
   PubMedGoogle Scholar
• Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4 + T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993; 178: 567–77.
   PubMed Web of Science ®Google Scholar
• Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 1993; 177: 1505–9.
   Google Scholar
• Sypek JP, Chung CL, Mayor SEH, Subramanyam JM, Goldman SJ, Sieburth DS, et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 response. J Exp Med 1993; 177: 1797–802.
   PubMed Web of Science ®Google Scholar
• Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri F, Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994; 263: 235–7.
   PubMed Web of Science ®Google Scholar
• Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, Bloom BR. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995; 155: 2515–24.
   PubMed Web of Science ®Google Scholar
• Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 1995; 84: 423–32.
   PubMed Web of Science ®Google Scholar
• Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280: 1432–5.
   Google Scholar
• de Jong R, Altare F, Haagen I-A, Elferink DG, de Boer T, van Breda Vriesman PJC, et al. Severe mycobacterial and salmonella infections in interleukin-12 receptor-deficient patients. Science 1998; 280: 1435–8.
   Google Scholar
• Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999; 285: 732–6.
   PubMed Web of Science ®Google Scholar
• Braun V, Hantke K. Biochemistry of bacterial cell envelopes. Annu Rev Biochem 1974; 43: 89–121.
   PubMed Web of Science ®Google Scholar
• Radolf JD, Chamberlain NR, Clausell A, Norgard MV. Identification and localization of integral membrane proteins of virulent Treponema pallidum subsp. pallidum by phase partitioning with the nonionic detergent triton X-114. Infect Immun 1988; 56: 490–8.
   PubMed Web of Science ®Google Scholar
• Chamberlain NR, Brandt ME, Erwin AL, Radolf JD, Norgard MV. Major integral membrane protein immunogens of Treponema pallidum are proteolipids. Infect Immun 1989; 57: 2872–7.
   PubMed Web of Science ®Google Scholar
• Bricker TM, Boyer MJ, Keith J, Watson-McKown R, Wise KS. Association of lipids with integral membrane surface proteins of Mycoplasma hyorhinis. Infect Immun 1988; 56: 295–301.
   Google Scholar
• Weis JJ, Ma Y, Erdile LF. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun 1994; 62: 4632–6.
   Google Scholar
• Radolf JD, Arndt LL, Akins DR, Curetty LL, Levi ME, Shen Y, et al. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/ macrophages. J Immunol 1995; 154: 2866–77.
   PubMed Web of Science ®Google Scholar
• Melchers F, Braun V, Galanos C. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J Exp Med 1975; 142: 473–82.
   Google Scholar
• Biesert L, Scheuer W, Bessler WG. Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes. Isolation and characterization of binding proteins. Eur J Biochem 1987; 162: 651–7.
   Google Scholar
• Hauschildt S, Hoffmann P, Beuscher HU, Dufhues G, Heinrich P, Wiesmuller KH, et al. Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Eur J Immunol 1990; 20: 63–8.
   PubMedGoogle Scholar
• Bessler WG, Ottenbreit BP. Studies on the mitogenic principle of the lipoprotein from the outer membrane of Escherichia coli. Biochem Biophys Res Commun 1976; 76: 239–46.
   PubMedGoogle Scholar
• Bessler WG, Cox M, Lex A, Suhr B, Wiesmuller KH, Jung G. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. J Immunol 1985; 135: 1900–5.
   PubMedGoogle Scholar
• Hoffmann P, Heinle S, Schade UF, Loppnow H, Ulmer AJ, Flad HD, et al. Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology 1988; 177: 158–70.
   PubMed Web of Science ®Google Scholar
• Ma Y, Seiler KP, Tai KF, Yang L, Woods M, Weis JJ. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect Immun 1994; 62: 3663–71.
   PubMed Web of Science ®Google Scholar
• Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent M. tuberculosis by the reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992; 175: 1111–22.
   Google Scholar
• Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 1995; 63: 736–40.
   Google Scholar
• MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997; 94: 5243–8.
   PubMed Web of Science ®Google Scholar
• Xie QW, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 1993; 177: 1779–84.
   Google Scholar
• Aliprantis AO, Yang R-B, Mark MR, Suggett S, Devaux B, Radolf JD, et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 1999; 285: 736–9.
   PubMed Web of Science ®Google Scholar
• Aliprantis AO, Yang RB, Weiss DS, Godowski P, Zychlinsky A. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J 2000; 19: 3325–36.
   Google Scholar
• Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, Morr M, et al. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol 2000; 164: 554–7.
   PubMed Web of Science ®Google Scholar